UK cushions hospitals reform with medtech-boosting £200 million
This article was originally published in Clinica
Executive Summary
The UK has pledged to invest £200m ($323m) over four years as part of a programme to raise standards across the NHS and help hospitals achieve Foundation status. The hospitals most likely to benefit would be those who are short of the three-star performance rating required. The initiative promises to be an important medical technology boost in the priority areas of healthcare on which performance is assessed.
You may also be interested in...
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.
Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire
Clarke helped launch GDUFA I and negotiate GDUFA II, chaired the CDER Executive Committee and oversaw many other programs in the US FDA’s drugs center.